EUVIMEDEUVIMED entdecken
Crossref

Montelukast: Pharmacology, Safety, Tolerability and Efficacy

Michael S. Benninger, Heather Waters

Clinical Medicine. Therapeutics · 2009

DOI: 10.4137/cmt.s1147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine. Therapeutics, 2009. Verfasst von Michael S. Benninger und 1 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic rhinitis and asthma are common disorders effecting large percentages of the population of Western countries. There are multiple treatment options available for allergic rhinitis and asthma and stepwise approaches to therapy have been recommended. Montelukast is a cysteinyl leukotriene receptor antagonist that has been found to be effective both in the treatment of allergic rhinitis and asthma. This paper will describe the pharmacology, safety, efficacy and tolerability of montelukast. It will examine the comparative efficacy of montelukast to other medications for the treatment of allergic rhinitis and asthma, as well as discuss the recent studies of combination therapy.

Zitieren

APA

Benninger, M. S., & Waters, H. (2009). Montelukast: Pharmacology, Safety, Tolerability and Efficacy. Clinical Medicine. Therapeutics. https://doi.org/10.4137/cmt.s1147

Vancouver

Benninger MS, Waters H. Montelukast: Pharmacology, Safety, Tolerability and Efficacy. Clinical Medicine. Therapeutics. 2009. doi:10.4137/cmt.s1147

BibTeX
@article{Benninger2009,
  author = {Benninger, Michael S. and Waters, Heather},
  title = {Montelukast: Pharmacology, Safety, Tolerability and Efficacy},
  journal = {Clinical Medicine. Therapeutics},
  year = {2009},
  doi = {10.4137/cmt.s1147}
}
Kostenlos starten →